Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leuprolide × Other × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 85 Breast 15 Head & Neck 3 Plasma cell 2 Other hematologic neoplasm 2 Myeloid 2 Lymphoid 2 Tumor-Agnostic 1 Other 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Obesity, Morbid 1

Interventions

Radiotherapy 5 Surveys and Questionnaires 4 Cisplatin 4 angiotensin I (1-7) 3 alvimopan 3 Radiation 3 Injections 3 Water 2 Vitamin D 2 Tirzepatide 2 RRx-001 2 Mouthwashes 2 Interleukin 1 Receptor Antagonist Protein 2 Drug Therapy 2 Dexmedetomidine 2 Dexamethasone 2 Calcium Dobesilate 2 Amifostine 2 Acetylcysteine 2 tempol 1 peppermint oil 1 pegfilgrastim 1 naloxegol 1 methylnaltrexone 1 linaclotide 1 licogliflozin 1 kang-lai-te 1 isatuximab 1 indole-3-carbinol 1 hydrated silica gel-based toothpaste 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04331717 2022-05-02

BASH-PC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Obesity, Morbid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡